Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00399841 · ClinicalTrials.gov registry record · NA

Spinal Cord Stimulation (SCS) for Neuropathic Pain of Back or Lower Extremity

A NA study, sponsored by Boston Scientific Corporation.

Terminated
Registry status
NA
Development phase
13
Enrollment target

NCT00399841 is a NA study that was terminated before completion, run by Boston Scientific Corporation. The registered enrollment target is 13 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00399841, a NA study, was terminated before completion, sponsored by Boston Scientific Corporation.

TERMINATED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

The primary objective of this study is to compare the efficacy and patient preference for spinal cord stimulation (SCS) using the Precision device with the electrode array placed at T7 versus placement at T8. Eligible patients will have chronic intractable pain in the back or lower extremities and will have independently elected SCS as the next line of therapy. There is some anecdotal evidence that the coverage of the paresthesia resulting from T7 placement is preferable to that obtained by the more commonly used T8 placement but there has been no study to support this observation.

Interventions

  • DEVICE Precision for Spinal Cord Stimulation

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2006-11
Est. Completion 2008-11
Phase NA

Sponsor

Boston Scientific Corporation

280 total trials

What the Registry Record Tells You About NCT00399841

The ClinicalTrials.gov registry entry for NCT00399841 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Precision for Spinal Cord Stimulation is the first listed.

NCT00399841 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00399841 about?

NCT00399841 is a clinical study titled "Spinal Cord Stimulation (SCS) for Neuropathic Pain of Back or Lower Extremity". The primary objective of this study is to compare the efficacy and patient preference for spinal cord stimulation (SCS) using the Precision device with the electrode array placed at T7 versus placement at T8. Eligible patients will have chronic intractable pain in the back or lower extremities and w...

What is the current status of trial NCT00399841?

This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2006-11. Estimated completion is 2008-11.

What interventions are being tested in trial NCT00399841?

The interventions under investigation include: Precision for Spinal Cord Stimulation (DEVICE).

Who is sponsoring clinical trial NCT00399841?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.